• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Pathophysiology of Blister Formation in Bullous Pemphigoid
Dermatology
2 min
expert video

Pathophysiology of Blister Formation in Bullous Pemphigoid

Prurigo Nodularis Myths and Facts
Dermatology
13 min
expert video

Prurigo Nodularis Myths and Facts

Role of Type 2 Inflammation in Prurigo Nodularis Part 2: Itch and Skin Lesions
Dermatology
13 min
expert video

Role of Type 2 Inflammation in Prurigo Nodularis Part 2: Itch and Skin Lesions

Role of Type 2 Inflammation in Prurigo Nodularis         Part 1: Overview of Type 2 Inflammation
Dermatology
8 min
expert video

Role of Type 2 Inflammation in Prurigo Nodularis Part 1: Overview of Type 2 Inflammation

Overview of Prurigo Nodularis Part 2: Burden of Disease and Considerations of Patient Care
Dermatology
5 min
expert video

Overview of Prurigo Nodularis Part 2: Burden of Disease and Considerations of Patient Care

Overview of Prurigo Nodularis Part 1: Clinical Features, Epidemiology, and Diagnosis
Dermatology
9 min
expert video

Overview of Prurigo Nodularis Part 1: Clinical Features, Epidemiology, and Diagnosis

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in BP
Dermatology
15 min
expert video

Mechanisms of Disease: Autoimmunity and Role of Type 2 Inflammation in Bullous Pemphigoid (BP)

What We Know About Bullous Pemphigoid (BP): Challenges of the Various Clinical Manifestations, Diagnosis, and Burden for Patients and Caregiver
Dermatology
10 min
expert video

What We Know About Bullous Pemphigoid (BP): Challenges of the Various Clinical Manifestations, Diagnosis, and Burden for Patients and Caregivers

Unmet Needs for Bullous Pemphigoid (BP): Limitations of Diagnosis and Conventional Therapies
Dermatology
10 min
expert video

Unmet Needs for Bullous Pemphigoid (BP): Limitations of Diagnosis and Conventional Therapies

How Can FeNO Measurement Improve Severe Asthma Management?
Pulmonology
7 min
expert video

How Can FeNO Measurement Improve Severe Asthma Management?

The Role of IL-4 and IL-13 in CSU
Dermatology
5 min
Infographic

The Role of IL-4 and IL-13 in CSU

Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology
Dermatology
40 min
expert video

Navigating Atopic Dermatitis and Hand and Foot Dermatitis: Clinical Manifestations and Pathophysiology

    1
    ...
    131415
    ...
    25